Farnesyltransferase inhibitor lonafarnib suppresses respiratory syncytial virus infection by blocking conformational change of fusion glycoprotein
2024 · Signal Transduction and Targeted Therapy · 21 citations
https://doi.org/10.1038/s41392-024-01858-5